|
Market Closed -
Nasdaq
16:00:00 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 1.170 USD | -4.88% |
|
-4.10% | -11.36% |
| 08-05 | Geron Corporation Provides Earnings Guidance for 2026 | CI |
| 08-05 | Geron Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GERON CORPORATION | Bio Therapeutic Drugs | -4.88% | -4.10% | -11.36% | -8.59% | -17.02% | 790M |  |  | |
- Stock Market
- Stocks
- GERN Stock
- Charts Geron Corporation
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
